Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 539

1.

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC; Chronic Hepatitis Cohort Study (CHeCS) Investigators.

Clin Infect Dis. 2013 Jul;57(2):240-6. doi: 10.1093/cid/cit245. Epub 2013 Apr 16.

2.

APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS).

Teshale E, Lu M, Rupp LB, Holmberg SD, Moorman AC, Spradling P, Vijayadeva V, Boscarino JA, Schmidt MA, Gordon SC; CHeCS Investigators.

J Viral Hepat. 2014 Dec;21(12):917-20. doi: 10.1111/jvh.12279. Epub 2014 Aug 1.

PMID:
25131445
3.

Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.

Amorim TG, Staub GJ, Lazzarotto C, Silva AP, Manes J, Ferronato Mda G, Shiozawa MB, Narciso-Schiavon JL, Dantas-Correa EB, Schiavon Lde L.

Ann Hepatol. 2012 Nov-Dec;11(6):855-61.

4.

The validity of serum markers for fibrosis staging in chronic hepatitis B and C.

Li J, Gordon SC, Rupp LB, Zhang T, Boscarino JA, Vijayadeva V, Schmidt MA, Lu M; Chronic Hepatitis Cohort Study (CHeCS) Investigators.

J Viral Hepat. 2014 Dec;21(12):930-7. doi: 10.1111/jvh.12224. Epub 2014 Jan 29.

PMID:
24472062
5.

[Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].

Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.

Korean J Hepatol. 2009 Dec;15(4):454-63. doi: 10.3350/kjhep.2009.15.4.454. Korean.

6.

Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.

Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.

J Coll Physicians Surg Pak. 2009 Aug;19(8):478-82. doi: 08.2009/JCPSP.478482.

PMID:
19651008
7.

Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.

Schiavon LL, Narciso-Schiavon JL, Carvalho Filho RJ, Sampaio JP, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML.

J Viral Hepat. 2008 Sep;15(9):666-74. doi: 10.1111/j.1365-2893.2008.00992.x. Epub 2008 May 14.

PMID:
18482283
8.

Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.

Fouad SA, Esmat S, Omran D, Rashid L, Kobaisi MH.

World J Gastroenterol. 2012 Jun 21;18(23):2988-94. doi: 10.3748/wjg.v18.i23.2988.

9.

Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection.

Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, Liu L, Lei XZ, Liu C, Tang H.

Dig Dis Sci. 2011 Sep;56(9):2742-9. doi: 10.1007/s10620-011-1659-1. Epub 2011 Mar 12.

PMID:
21399926
10.

Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.

Ma J, Jiang Y, Gong G.

Eur J Gastroenterol Hepatol. 2013 Apr;25(4):428-34. doi: 10.1097/MEG.0b013e32835cb5dd.

PMID:
23358121
11.

The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.

Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C.

Scand J Clin Lab Invest. 2014 Apr;74(3):240-7. doi: 10.3109/00365513.2013.879392. Epub 2014 Jan 24.

PMID:
24460024
12.

Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.

Elesawy BH, Abd El Hafez A, Dorgham LS, El-Askary A.

Pathol Res Pract. 2014 Dec;210(12):922-8. doi: 10.1016/j.prp.2014.07.005. Epub 2014 Jul 22.

PMID:
25123964
13.

APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.

Ucar F, Sezer S, Ginis Z, Ozturk G, Albayrak A, Basar O, Ekiz F, Coban S, Yuksel O, Armutcu F, Akbal E.

Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1076-81. doi: 10.1097/MEG.0b013e32835fd699.

PMID:
23510962
14.

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.

Hepatology. 2005 Jun;41(6):1376-82.

PMID:
15915455
15.

A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI).

Ahmad W, Ijaz B, Javed FT, Gull S, Kausar H, Sarwar MT, Asad S, Shahid I, Sumrin A, Khaliq S, Jahan S, Pervaiz A, Hassan S.

BMC Gastroenterol. 2011 Apr 21;11:44. doi: 10.1186/1471-230X-11-44.

16.

Validation of APRI and FIB-4 score in an Antwerp cohort of chronic hepatitis C patients.

Verlinden W, Bourgeois S, De Maeyer M, Vonghia L, Vanwolleghem T, Michielsen P, Francque S.

Acta Gastroenterol Belg. 2015 Dec;78(4):373-80.

PMID:
26712046
17.

[Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].

González Guilabert MI, Hinojosa Mena-Bernal C, del Pozo González J, del Pozo Pérez MA.

Gastroenterol Hepatol. 2010 Jun-Jul;33(6):425-32. doi: 10.1016/j.gastrohep.2010.02.005. Epub 2010 May 14. Spanish.

PMID:
20471720
18.

APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.

Pissaia A Jr, Borderie D, Bernard D, Scatton O, Calmus Y, Conti F.

Transplant Proc. 2009 Mar;41(2):679-81. doi: 10.1016/j.transproceed.2008.12.014.

PMID:
19328955
19.

The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.

Snyder N, Nguyen A, Gajula L, Soloway R, Xiao SY, Lau DT, Petersen J.

Clin Chim Acta. 2007 Jun;381(2):119-23. Epub 2007 Mar 19.

PMID:
17442291
20.

Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?

Cheung RC, Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR; VA HCV-001 Study Group.

J Clin Gastroenterol. 2008 Aug;42(7):827-34. doi: 10.1097/MCG.0b013e318046ea9a.

PMID:
18285716
Items per page

Supplemental Content

Write to the Help Desk